USA - NASDAQ:CMPX - US20454B1044 - Common Stock
Taking everything into account, CMPX scores 3 out of 10 in our fundamental rating. CMPX was compared to 536 industry peers in the Biotechnology industry. While CMPX has a great health rating, there are worries on its profitability. CMPX does not seem to be growing, but still is valued expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -42.31% | ||
ROE | -52.97% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 10.93 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 7.66 | ||
Quick Ratio | 7.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:CMPX (9/29/2025, 10:01:04 AM)
3.695
-0.05 (-1.2%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 745.82 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 6.8 | ||
P/tB | 6.8 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -42.31% | ||
ROE | -52.97% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 6.11% | ||
Cap/Sales | 7.29% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 7.66 | ||
Quick Ratio | 7.66 | ||
Altman-Z | 10.93 |